DE1792346B2 - - Google Patents

Info

Publication number
DE1792346B2
DE1792346B2 DE1792346A DE1792346A DE1792346B2 DE 1792346 B2 DE1792346 B2 DE 1792346B2 DE 1792346 A DE1792346 A DE 1792346A DE 1792346 A DE1792346 A DE 1792346A DE 1792346 B2 DE1792346 B2 DE 1792346B2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1792346A
Other versions
DE1792346A1 (de
DE1792346C3 (de
Inventor
Luigi Rovati
Sergio Mascherpa
Pier Luigi Casula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Priority to DE1792346A priority Critical patent/DE1792346C3/de
Priority to US851446A priority patent/US3697652A/en
Priority to FR696928696A priority patent/FR2016182B1/fr
Publication of DE1792346A1 publication Critical patent/DE1792346A1/de
Publication of DE1792346B2 publication Critical patent/DE1792346B2/de
Application granted granted Critical
Publication of DE1792346C3 publication Critical patent/DE1792346C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE1792346A 1968-08-22 1968-08-22 Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen Expired DE1792346C3 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE1792346A DE1792346C3 (de) 1968-08-22 1968-08-22 Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
US851446A US3697652A (en) 1968-08-22 1969-08-19 N-acetylglucosamine for treating degenerative afflictions of the joints
FR696928696A FR2016182B1 (de) 1968-08-22 1969-08-21

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1792346A DE1792346C3 (de) 1968-08-22 1968-08-22 Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen

Publications (3)

Publication Number Publication Date
DE1792346A1 DE1792346A1 (de) 1971-11-11
DE1792346B2 true DE1792346B2 (de) 1980-02-28
DE1792346C3 DE1792346C3 (de) 1980-10-23

Family

ID=5707380

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1792346A Expired DE1792346C3 (de) 1968-08-22 1968-08-22 Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen

Country Status (3)

Country Link
US (1) US3697652A (de)
DE (1) DE1792346C3 (de)
FR (1) FR2016182B1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
FR2187324B1 (de) * 1972-06-14 1975-06-20 Rech Pharmaceut Sc
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
US4323561A (en) * 1977-09-06 1982-04-06 Temple University Of The Commonwealth System Of Higher Education Process of enhancing immmunogenic response in mammals by the administration of synthetic glycolipid adjuvants
DE3220426A1 (de) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg Chemische verbindung, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der malaria
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
DE3927723A1 (de) * 1989-01-26 1990-08-02 Ulrich Prof Dr Speck N - acetylglucosamin zur buccalen anwendung
US5217962A (en) * 1992-01-28 1993-06-08 Burton Albert F Method and composition for treating psoriasis
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
US5192750A (en) * 1992-01-28 1993-03-09 The University Of British Columbia Method and composition for treatment of food allergy
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
ATE293451T1 (de) * 1996-12-13 2005-05-15 Lescarden Inc Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6046179A (en) * 1998-04-17 2000-04-04 Murch; Simon Composition for and treatment of inflammatory bowel disease by colon administration of N-acetylglucosamine
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
JP2003507400A (ja) 1999-08-20 2003-02-25 ハワード ムラード セリュライトの出現を軽減する医薬組成物及び方法
US7214666B1 (en) 1999-11-02 2007-05-08 Shawn Paul Madere Composition of orally administered nutritional supplements to repair articular cartilage
US6608041B2 (en) 2000-02-18 2003-08-19 Milton Hammerly Analgesics combined with naturally-occurring chondroprotective agents
US6689399B1 (en) 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
EP1175906B1 (de) * 2000-07-18 2005-11-09 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blutfluss verbesserers und Thrombosis Präventiven mit Glucosamine
CA2317305A1 (en) * 2000-08-29 2002-02-28 Tassos P. Anastassiades Method of enhancing chondrocyte cell growth and glycosaminoglycan production
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
US20080003258A1 (en) * 2002-10-16 2008-01-03 Marcum Frank D Composition and Method for Treating Rheumatoid Arthritis
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US6979679B2 (en) 2002-10-16 2005-12-27 Marcum Frank D Composition and method for treatment and prevention of traumatic synovitis and damage to articular cartilage
US7485629B2 (en) * 2002-10-16 2009-02-03 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treatment of joint damage
US20060046975A1 (en) * 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
ATE403412T1 (de) 2002-12-10 2008-08-15 Gambro Lundia Ab Verfahren zur herstellung einer medizinischen lösung zur herstellung eines medikaments für die peritonealdialyse
CA2479632C (en) * 2004-08-31 2011-07-26 Tassos Anastassiades Method for increasing the bone mineral density of a mammal using n-acylated glucosamines
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
ITTO20070210A1 (it) 2007-03-22 2008-09-23 Rottapharm Spa Composizioni contenenti n-acetilglucosamina per l'impiego in dermocosmesi e medicina estetica
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
JP5689458B2 (ja) 2009-05-13 2015-03-25 ワイス・エルエルシー グルコサミンを包含する栄養補助食品を安定化させる方法
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
CA3008722C (en) * 2018-06-19 2023-06-20 Purepharm Inc. Excipient free glucosamine tablets and method of making

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232836A (en) * 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine

Also Published As

Publication number Publication date
FR2016182A1 (de) 1970-05-08
US3697652A (en) 1972-10-10
FR2016182B1 (de) 1973-01-12
DE1792346A1 (de) 1971-11-11
DE1792346C3 (de) 1980-10-23

Similar Documents

Publication Publication Date Title
FR2016182B1 (de)
AU428130B2 (de)
AU5184069A (de)
AU6168869A (de)
AU6171569A (de)
AU429879B2 (de)
AU4304568A (de)
AU4811568A (de)
AR203075Q (de)
AU4744468A (de)
BE630165A (de)
BE709479A (de)
BE709138A (de)
BE709119A (de)
BE709095A (de)
BE708951A (de)
BE708933A (de)
BE708888A (de)
BE642636A (de)
BE709301A (de)
BE709319A (de)
BE709320A (de)
BE581157A (de)
BE709415A (de)
BE709435A (de)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8328 Change in the person/name/address of the agent

Free format text: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL.-ING., PAT.-ANW., 4000 DUESSELDORF